X2KB317
Bypass Radial Artery, Right to New Technology Group 7 with Thermal Resistance Energy, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | K Bypass |
| Body Part | B Radial Artery, Right |
| Approach | 3 Percutaneous |
| Device | 1 Thermal Resistance Energy |
| Qualifier | 7 New Technology Group 7 |
Operation Definition
Altering the route of passage of the contents of a tubular body part
Procedure Overview
This family covers rerouting blood flow around a diseased or blocked vessel using a new technology conduit or device not yet captured by standard bypass codes. Traditional coronary or peripheral bypass uses a harvested vein or synthetic graft; procedures in this group involve a novel material or delivery method that has been granted distinct New Technology status, such as an engineered conduit designed to improve long-term patency. The clinical goal remains the same as any bypass: restoring adequate blood supply to tissue starved by an obstruction.
Patients undergoing these procedures are often part of a defined population where the newer conduit or technique has shown a specific advantage, such as reduced graft failure, over conventional grafting materials.
Anatomy & Axis Detail
Radial Artery, Right
The right radial artery, a superficial forearm vessel commonly used for catheter access and surgical dialysis fistulas, is the body part when Bypass is reported here under New Technology. Rather than an open surgical anastomosis, this typically reflects a percutaneous, catheter-based technique that uses magnetic or radiofrequency alignment to fuse the radial artery to its adjacent vein, creating an arteriovenous connection without a skin incision at the fistula site. The resulting fistula matures over subsequent weeks to support hemodialysis access. Because the artery itself is not excised or grafted, coding hinges on recognizing that the device-driven percutaneous approach, rather than conventional suture technique, is what qualifies the procedure for a New Technology value.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Thermal Resistance Energy
This value denotes an energy modality that works by inducing controlled thermal resistance in tissue, generating heat through resistive effects to achieve an ablative or modifying effect. It is distinguished from other energy types, such as direct radiofrequency or ultrasound cavitation, by its specific thermal-resistance mechanism of action. The qualifier identifies how energy was delivered rather than the target anatomy.
Qualifier: New Technology Group 7
As a qualifier value, Group 7 marks a code as belonging to the set of new technologies approved for use in the 2020-2021 fiscal year, a period that included a notable expansion of infectious-disease-related add-on codes. The label does not describe what the technology does; that detail sits in the table and other axis values. It is distinguished from adjoining groups solely by its approval-year cohort.
Coding & Documentation
Coders must confirm the operative report names the specific device or conduit listed in the New Technology reference table, along with the two body parts connected by the bypass, since the code identifies both the origin and the route of the rerouted flow. A frequent assignment error is selecting the standard section Bypass code when the graft material actually qualifies for New Technology designation, or reversing the coded direction of blood flow described in the qualifier. Documentation should also clearly distinguish a true bypass, which creates an alternate route while leaving the diseased segment in place, from removal or replacement of the diseased segment itself.
Commonly Confused With
This family is frequently confused with standard Cardiovascular Bypass procedures, where the deciding factor is exclusively whether the conduit or device is included in the current New Technology table. It also differs from Replacement, since a bypass leaves the original diseased vessel in place and adds an alternate route rather than substituting the vessel's structure.